OTP, CD44, and Ki-67: A prognostic marker panel for relapse free survival in patients with surgically resected pulmonary carcinoid.

Autor: Moonen L; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands., Derks JL; Department of Pulmonary Diseases, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands., den Bakker MA; Department of Pathology, Maasstad Hospital, Rotterdam, the Netherlands., Hillen LM; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands., Jan van Suylen R; Pathology-DNA, location Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands., von der Thüsen JH; Department of Pathology and Clinical Bioinformatics, Erasmus MC, Rotterdam, the Netherlands., Lap LMV; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands., Marijnissen BJCA; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands., Damhuis RA; Department Research, Comprehensive Cancer Association, Utrecht, the Netherlands., Smits KM; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands., van den Broek EC; PALGA foundation, Houten, the Netherlands., Buikhuisen WA; Department of Thoracic Oncology, Netherlands Cancer Institute Amsterdam, The Netherlands., Dingemans AC; Department of Pulmonary Diseases, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands; Department of pulmonology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands., Speel EJM; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands; Department of Pathology and Clinical Bioinformatics, Erasmus MC, Rotterdam, the Netherlands. Electronic address: e.speel@erasmusmc.nl.

Publikováno v: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2024 Dec 02, pp. 100677. Date of Electronic Publication: 2024 Dec 02.

Prediction of molecular subclasses of uveal melanoma by deep learning using routine haematoxylin-eosin-stained tissue slides.

Autor: Akram F; Department of Pathology and Clinical Bioinformatics, Erasmus MC Rotterdam, Rotterdam, the Netherlands., de Bruyn DP; Ophthalmology, Erasmus MC Rotterdam, Rotterdam, the Netherlands.; Clinical Genetics, Erasmus MC Rotterdam, Rotterdam, the Netherlands.; Cancer Institute, Erasmus MC Rotterdam, Rotterdam, the Netherlands., van den Bosch QCC; Ophthalmology, Erasmus MC Rotterdam, Rotterdam, the Netherlands.; Clinical Genetics, Erasmus MC Rotterdam, Rotterdam, the Netherlands.; Cancer Institute, Erasmus MC Rotterdam, Rotterdam, the Netherlands., Trandafir TE; Department of Pathology and Clinical Bioinformatics, Erasmus MC Rotterdam, Rotterdam, the Netherlands., van den Bosch TPP; Department of Pathology and Clinical Bioinformatics, Erasmus MC Rotterdam, Rotterdam, the Netherlands., Verdijk RM; Department of Pathology and Clinical Bioinformatics, Erasmus MC Rotterdam, Rotterdam, the Netherlands., de Klein A; Ophthalmology, Erasmus MC Rotterdam, Rotterdam, the Netherlands.; Cancer Institute, Erasmus MC Rotterdam, Rotterdam, the Netherlands., Kiliç E; Ophthalmology, Erasmus MC Rotterdam, Rotterdam, the Netherlands.; Cancer Institute, Erasmus MC Rotterdam, Rotterdam, the Netherlands., Stubbs AP; Department of Pathology and Clinical Bioinformatics, Erasmus MC Rotterdam, Rotterdam, the Netherlands., Brosens E; Clinical Genetics, Erasmus MC Rotterdam, Rotterdam, the Netherlands.; Cancer Institute, Erasmus MC Rotterdam, Rotterdam, the Netherlands., von der Thüsen JH; Department of Pathology and Clinical Bioinformatics, Erasmus MC Rotterdam, Rotterdam, the Netherlands.

Publikováno v: Histopathology [Histopathology] 2024 Dec; Vol. 85 (6), pp. 909-919. Date of Electronic Publication: 2024 Jul 01.

Differentiating Separate Primary Lung Adenocarcinomas From Intrapulmonary Metastases With Emphasis on Pathological and Molecular Considerations: Recommendations From the International Association for the Study of Lung Cancer Pathology Committee.

Autor: Chou TY; Department of Pathology and Precision Medicine Research Center, Taipei Medical University Hospital and Graduate Institute of Clinical Medicine, School of Medicine and Precision Health Center, Taipei Medical University, Taipei, Taiwan. Electronic address: tehying@tmu.edu.tw., Dacic S; Department of Pathology, Yale School of Medicine, New Haven, Connecticut., Wistuba I; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Beasley MB; Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York., Berezowska S; Department of Laboratory Medicine and Pathology, Institute of Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Chang YC; Department of Medical Imaging, National Taiwan University Hospital, Taipei, Taiwan., Chung JH; Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea., Connolly C; International Association for the Study of Lung Cancer, Denver, Colorado., Han Y; Department of Pathology, Shanghai Chest Hospital, Jiaotong University, Shanghai, People's Republic of China., Hirsch FR; Center for Thoracic Oncology, The Tisch Cancer Institute, New York, New York and Icahn School of Medicine, Mount Sinai Health System, New York, New York., Hwang DM; Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Odette Cancer Centre, Ontario, Canada., Janowczyk A; Department of Biomedical Engineering, Emory University and Georgia Institute of Technology, Atlanta, Georgia., Joubert P; Institut Universitaire de Cardiologie et de Pneumologie de Quebec - Université Laval, Quebec City, Canada., Kerr KM; Department of Pathology, Aberdeen University School of Medicine and Aberdeen Royal Infirmary, Aberdeen, Scotland., Lin D; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) and Department of Pathology, Peking University Cancer Hospital & Institute, Beijing, People's Republic of China., Minami Y; Department of Pathology, National Hospital Organization Ibarakihigashi National Hospital, The Center of Chest Diseases and Severe Motor & Intellectual Disabilities, Tokai, Ibaraki, Japan., Mino-Kenudson M; Department of Pathology, Massachusetts General Hospital & Harvard Medical School, Boston, Massachusetts., Nicholson AG; Department of Histopathology, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust and National Heart and Lung Institute, Imperial College, London, United Kingdom., Papotti M; Department of Oncology, University of Turin, Torino, Italy., Rekhtman N; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Roden AC; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., von der Thüsen JH; Department of Pathology, Erasmus MC, Rotterdam, The Netherlands., Travis W; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Tsao MS; Department of Pathology, University Health Network and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada., Yatabe Y; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan., Yeh YC; Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital and Department of Pathology, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan., Bubendorf L; Institute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, Basel, Switzerland., Chang WC; Department of Pathology, Taipei Medical University Hospital and Taipei Medical University, Taipei, Taiwan., Denninghoff V; Molecular-Clinical Laboratory, University of Buenos Aires-National Council for Scientific and Technical Research (CONICET), Buenos Aires, Argentina., Fernandes Tavora FR; Department of Pathology and Forensic Medicine, Faculty of Medicine, Federal University of Ceará, Fortaleza, Brazil., Hayashi T; Department of Human Pathology, Juntendo University Faculty of Medicine, Tokyo, Japan., Hofman P; Laboratory of Clinical and Experimental Pathology, Hôpital Pasteur, Centre Hospitalier Universitaire de Nice, Université Côte d'Azur, Nice, France., Jain D; Department of Pathology, All India Institute of Medical Sciences, New Delhi, India., Kim TJ; Department of Hospital Pathology, Yeouido St. Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea., Lantuejoul S; Université de Grenoble Alpes, Grenoble and Department of Pathology, Centre Leon Berard, Lyon, France., Le Quesne J; Beatson Cancer Research Institute, University of Glasgow, NHS Greater Glasgow and Clyde Glasgow, Glasgow, United Kingdom., Lopez-Rios F; Pathology Department, Hospital Universitario 12 de Octubre, Madrid, Spain., Matsubara D; Department of Pathology, University of Tsukuba, Tsukuba, Ibaraki, Japan., Noguchi M; Department of Pathology, Narita Tomisato Tokushukai Hospital, Chiba, Japan., Radonic T; Department of Pathology, Amsterdam University Medical Center, Free University Amsterdam, Amsterdam, The Netherlands., Saqi A; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York., Schalper K; Department of Pathology and Medicine, Yale School of Medicine, New Haven, Connecticut., Shim HS; Department of Pathology, Yonsei University College of Medicine, Seoul, Republic of Korea., Sholl L; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Weissferdt A; Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston., Cooper WA; Royal Prince Alfred Hospital, NSW Health Pathology, Camperdown, New South Wales, Australia.

Publikováno v: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2024 Nov 22. Date of Electronic Publication: 2024 Nov 22.

Rapid On-Site Histology of Lung and Pleural Biopsies Using Higher Harmonic Generation Microscopy and Artificial Intelligence Analysis.

Autor: van Huizen LMG; Department of Physics, LaserLab Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. Electronic address: l.m.g.van.huizen@vu.nl., Blokker M; Department of Physics, LaserLab Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Daniels JMA; Department of Pulmonary Diseases, Amsterdam University Medical Centers, Amsterdam, The Netherlands., Radonic T; Department of Pathology, Amsterdam University Medical Centers, Amsterdam, The Netherlands., von der Thüsen JH; Department of Pathology, Erasmus MC, Rotterdam, The Netherlands., Veta M; Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands., Annema JT; Department of Pulmonary Diseases, Amsterdam University Medical Centers, Amsterdam, The Netherlands., Groot ML; Department of Physics, LaserLab Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Publikováno v: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2024 Oct 16; Vol. 38 (1), pp. 100633. Date of Electronic Publication: 2024 Oct 16.

A Response to the Letter to the Editor: Comment on "Clinical Utility of Circulating Tumor DNA in Patients With Advanced KRAS(G12C)-Mutated NSCLC Treated With Sotorasib".

Autor: Ernst SM; Department of Respiratory Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., von der Thüsen JH; Department of Pathology and Clinical Bioinformatics, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Dubbink HJ; Department of Pathology and Clinical Bioinformatics, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Dingemans AC; Department of Respiratory Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands. Electronic address: a.dingemans@erasmusmc.nl.

Publikováno v: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2024 Sep; Vol. 19 (9), pp. e44-e45.